An Etiopathological Study Of Vyanga With Special Reference To Melasma And Randomized Comparative Trial Of Mukhavyangaroga Nashaka Arka And Arjuna Twak Lepa. - NI

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•Subjects with Fitzpatrick skin types III, IV and V presenting with the classical signs and symptoms of Vyanga will be selected.
•Female subjects of childbearing potential using a reliable form of contraception during the course of the study excluding oral contraceptive pills at the time of the study or in the past 6 months (intrauterine device or condoms) or female of nonchildbearing potential (hysterectomy, bilateral ovariectomy or tubal section/ligation)
•Female subjects of childbearing potential with a negative urine pregnancy test before inclusion in the study Patient willing to follow up.

•Pregnant women, nursing mothers
•Subjects having known chronic, contagious infectious disease, such as active tuberculosis, hepatitis B or C, HIV
•Subjects suffering from other pigmentation disorders
•Subject having used any cosmetic depigmenting agent within 2 weeks prior to inclusion
•Subjects who have used a topical or inhaled corticosteroid or systemic steroids within 1 month prior to inclusion in the study
•Subjects having used topical tretinoin within 3 months or topical hydroquinone within 6 months prior to inclusion
•Subjects with history of endocrinopathies
•Hyperpigmentation caused since birth like nevus of ota.
•Hyperpigmentation caused by tumor like malignant melanoma, Known case of any active skin malignancy
•Vyanga along with other Kushtha roga to be excluded.

发起方